(Q62105214)

English

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Effects of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) Therapy (English)

0 references

medical condition

diabetes

0 references

country

United States of America

0 references

start time

April 2005

0 references

number of participants

90

0 references

research intervention

metformin

0 references

(RS)-rosiglitazone

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

completed

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT00110851

0 references

(Q62105214)

Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)